Projects Awarded $3.3 Million by Frankel Innovation Initiative

Fast Forward Medical Innovation (FFMI), a unit of the Medical School Office of Research, has awarded a combined $3.3 million in funding to four biomedical research projects in the inaugural round of the Frankel Innovation Initiative - a $20 million gift from the Maxine and Stuart Frankel Foundation to support the research and development of life-saving therapies at Michigan Medicine, in collaboration with other institutions.

The winning projects are U-M faculty-led, cover a range of disciplines, and have the potential for rapid clinical application and groundbreaking impact.

The projects focus on biomedical innovations that could quickly advance cutting-edge therapies and bring novel approaches to improving health into the hands of clinicians and scientists. Funded projects include:

  • Device to filter blood and treat sepsis in children – David Humes, M.D. (U-M) and Stuart Goldstein, M.D., FAAP, FNKF (Cincinnati Children’s Hospital)
  • System to keep donor organs alive outside the body – Alvaro Rojas-Pena, M.D. (U-M) and Robert Bartlett, M.D. (U-M)
  • Prosthetic hand that uses signals from the brain to move and sense – Paul Cederna, M.D. (U-M) and Cynthia Chestek, Ph.D. (U-M)
  • Device to help predict preterm birth – Molly Stout, M.D., MSCI (U-M), Methodius Tuuli, M.D., M.P.H., M.B.A. (Indiana University), and Peinan Zhao, Ph.D. (Washington University in St. Louis).

Researchers presented their proposals to the Frankels and a Scientific Advisory Committee of world-renowned scientists and technology development professionals external to U-M.

“We were extremely impressed with the high-caliber projects presented at the Frankel Innovation Initiative selection meeting,” says Thomas F. Bumol, Ph.D., Chair of the Scientific Advisory Committee, Executive Vice President of the Allen Institute, and Director of the Allen Institute for Immunology in Seattle. “U-M is a leader in translational medicine and at the forefront of biomedical innovation. We believe the winning projects possess the potential to have a tremendous impact on health and patient care around the world.”

In addition to providing their expertise and guidance to the Frankel investigators, the committee will leverage their combined experience to harness the creative ingenuity of the investigators and help direct the translation from cutting-edge innovation to life-saving medical practice.

The Frankel Innovation Initiative is designed to build on best practices of the standout programs developed at U-M and other top institutions, and capitalizes on U-M’s extensive biomedical research enterprise as the top public university in research spending in the United States. The $20 million gift will be used to fund four to seven projects annually, with each project receiving between $250,000 – $1 million.

“This very generous gift from the Frankels will take these four innovative projects to the next level,” says Marschall S. Runge, M.D., Ph.D. “The foresight and funding of this initiative will provide the critical support needed for these investigators to quickly move their innovations in areas of great patient need.”

The Initiative is administered by Fast Forward Medical Innovation, a group at Michigan Medicine that has the proven expertise and unique resources to work with faculty to bring together biomedical innovation and entrepreneurship and achieve life-saving results.

FFMI offers resources and support to world-class biomedical researchers at the university and across the state. This unit at U-M provides groundbreaking funding programs, dynamic educational offerings, and deep industry connections that help biomedical researchers navigate the road to successful innovation and commercialization, with the ultimate goal of positively impacting human health. For more information about FFMI, click here.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories Illustration of three older women playing cards at a table
Health Lab
Research needed on support for nontraditional caregivers providing care for people with Alzheimer’s disease and related dementias
A growing number of people living with Alzheimer’s disease and related dementias – especially those from diverse backgrounds – receive care from a network of individuals that increasingly includes nontraditional informal caregivers.
Aerial view of University of Michigan Health hospital in Ann Arbor, Michigan.
News Release
University of Michigan Health purchases land in Troy for new clinical facility
University of Michigan Health will purchase 7.28 acres of vacant land at the former Kmart headquarters location. U-M Health plans to build a multi-specialty facility on the property to expand specialty clinical services and increase patient access to the Oakland County region
George Mashour, M.D., Ph.D. standing in front of a bookcase, smiling. He is wearing a dark suit, white shirt, dark striped tie and dark framed glasses.
News Release
George Mashour, M.D., Ph.D. appointed senior associate dean for faculty and faculty development
George A. Mashour, M.D., Ph.D., has been appointed senior associate dean for faculty and faculty development of the University of Michigan Medical School by the U-M Board of Regents, effective May 1, 2024.
c.s_mott_childrens_hospital
News Release
$5.4M pediatric emergency services fast track clinic to serve lower acuity cases
University of Michigan Health C.S. Mott Children’s Hospital plans to build a $5.4 million emergency services fast track clinic to treat children, teens and young adults with lower acuity conditions.
Close up image of red blood cells moving through veins
Health Lab
Discovery reveals how this common stinky gas is processed to promote blood vessel growth
A new collaborative study, examined the interaction between three naturally occurring gases — nitric oxide (NO), oxygen, and H2S — during generation of new blood vessels, called angiogenesis.
Closeup of knee with caregiver holding the joint and examining it.
Health Lab
Lipid mediator Maresin 1 helps improve muscle regeneration
How lipid mediators -- potent regulators of the immune response after an injury -- varied with the acute loss of a large volume of skeletal muscle, also known as volumetric muscle loss (VML) is the focus of new research from the University of Michigan.